Leptin Resistance Exacerbates Diet-induced Obesity and is Associated with Diminished Maximal Leptin Signalling Capacity in Rats
Overview
Authors
Affiliations
Aims/hypothesis: Leptin resistance is generally considered a consequence of obesity. We postulated that leptin resistance is associated with diminished hypothalamic leptin signalling capacity and that leptin resistance is causal to obesity. We assessed maximal leptin-mediated binding of the transcription factor signal transducer and activator of transcription 3 (STAT3), and the response to high-fat feeding in lean leptin-resistant rats.
Materials And Methods: Recombinant adeno-associated virus encoding rat leptin cDNA (rAAV-leptin) or control vector were administered by intracerebroventricular injection to lean F344 x BN rats for up to 150 days, and food consumption, body weight, serum leptin and glucose tolerance were measured. Leptin-mediated hypothalamic transcription factor binding was assessed at day 150 following an intracerebroventricular injection of 2 mug leptin. Rats pretreated with either control or rAAV-leptin vector for 94 days were given a high-fat diet, and energy intake, body weight gain and adiposity were examined.
Results: The rAAV-leptin-treated rats initially responded to leptin gene delivery then became leptin-resistant. They displayed persistent submaximal hypothalamic leptin signalling and enhanced insulin sensitivity, yet maximal hypothalamic signalling capacity was decreased by more than 50%. On a high-fat diet, the leptin-resistant rats consumed more energy, gained more weight and accumulated greater visceral fat mass than controls.
Conclusions/interpretation: The maximal hypothalamic leptin signalling capacity was diminished in leptin-resistant rats receiving central rAAV-leptin gene therapy. Moreover, this leptin-invoked leptin resistance perturbs the regulation of energy homeostasis in response to high fat exposure, producing augmented energy consumption. This, coupled with potential hypersensitivity to insulin, creates a milieu favouring fat deposition. Our data suggest that leptin resistance is both a consequence and cause of obesity.
Moreira R, Oliveira P, Spadella M, Ferreira R, Alves M Antioxidants (Basel). 2025; 14(2).
PMID: 40002337 PMC: 11851673. DOI: 10.3390/antiox14020150.
Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions.
Wang T, Zhou D, Hong Z MedComm (2020). 2025; 6(1):e70030.
PMID: 39764565 PMC: 11702502. DOI: 10.1002/mco2.70030.
The Mechanism of Leptin Resistance in Obesity and Therapeutic Perspective.
Engin A Adv Exp Med Biol. 2024; 1460:463-487.
PMID: 39287862 DOI: 10.1007/978-3-031-63657-8_16.
A negative feedback loop between TET2 and leptin in adipocyte regulates body weight.
Zeng Q, Song J, Sun X, Wang D, Liao X, Ding Y Nat Commun. 2024; 15(1):2825.
PMID: 38561362 PMC: 10985112. DOI: 10.1038/s41467-024-46783-x.
Hyperleptinaemia and its Association with Postprandial Hypertriglyceridemia and Glucose Intolerance.
Aslam M, Madhu S, Sharma K, Sharma A, Galav V Indian J Endocrinol Metab. 2022; 25(5):443-449.
PMID: 35300449 PMC: 8923330. DOI: 10.4103/ijem.ijem_393_21.